MIRUM PHARMACEUTICALS INC's ticker is MIRM and the CUSIP is 604749101. A total of 112 filers reported holding MIRUM PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $11,170,853 | -68.0% | 353,508 | -73.8% | 3.54% | -32.4% |
| Q2 2023 | $34,924,500 | +156.1% | 1,350,000 | +137.7% | 5.23% | -19.1% |
| Q1 2023 | $13,639,181 | +126.5% | 567,826 | +83.9% | 6.47% | +96.9% |
| Q4 2022 | $6,021,132 | +0.6% | 308,776 | +8.3% | 3.28% | +2.4% |
| Q3 2022 | $5,988,000 | +90.5% | 285,000 | +76.4% | 3.21% | +29.5% |
| Q2 2022 | $3,143,000 | +93.1% | 161,527 | +118.5% | 2.48% | +135.7% |
| Q1 2022 | $1,628,000 | +54.8% | 73,930 | +22.7% | 1.05% | +116.3% |
| Q4 2020 | $1,052,000 | – | 60,250 | – | 0.49% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Frazier Life Sciences Management, L.P. | 6,470,392 | $204,464,387 | 13.58% |
| NEA Management Company, LLC | 2,186,243 | $69,085,279 | 5.34% |
| TANG CAPITAL MANAGEMENT LLC | 1,137,107 | $35,932,581 | 5.07% |
| BOONE CAPITAL MANAGEMENT LLC | 389,791 | $12,317,396 | 3.89% |
| Highlander Partners, L.P. | 122,980 | $3,886,168 | 3.84% |
| BVF INC/IL | 4,370,024 | $138,092,758 | 3.72% |
| Prosight Management, LP | 353,508 | $11,170,853 | 3.54% |
| Novo Holdings A/S | 1,500,000 | $47,400,000 | 3.50% |
| Nicholas Investment Partners, LP | 1,199,366 | $37,899,966 | 2.83% |
| Eventide Asset Management | 3,958,579 | $125,091,097 | 2.25% |